Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Bartziokas (Ioannina, Greece), C. Kyriakopoulos (Ioannina, Greece), E. Dounousi (Ioannina, Greece), G. Gkrepi (Ioannina, Greece), K. Kostikas (Ioannina, Greece). The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease. 1145

Member's Comments

No comment yet.

Related content which might interest you: Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Predictive factors for readmission of patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Chronic Obstructive Pulmonary Disease Exacerbations Source: Eur Respir Rev 2009; 18: 305 Year: 2009 Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir Rev 2009; 18: 133 Year: 2009 Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients. Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Minimal clinically important difference in Barthel dyspnoea after pulmonary rehabilitation in patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Novelties in pulmonary rehabilitation and chronic respiratory care Year: 2020 Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD). Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Effects of a self-management program in exacerbated Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Airway infection in COPD Year: 2019 Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision Source: Eur Respir J, 56 (1) 2000627; 10.1183/13993003.00627-2020 Year: 2020 Chronic obstructive pulmonary disease (COPD) and alterations of hemogram Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021